Human cancer cells, particularly from aggressive tumors like PDAC, secrete Gal-9 in response to interactions with T lymphocytes, which leads to suppression of the immune response through mechanisms such as inhibition of T cell function and macrophage programming. This evidence concerns the gene LGALS9 and cancer.